Volume 59, Issue 5, Pages (May 2001)

Slides:



Advertisements
Similar presentations
Volume 67, Issue 1, Pages (January 2005)
Advertisements

Volume 59, Issue 5, Pages (May 2001)
Volume 67, Issue 3, Pages (March 2005)
Volume 59, Issue 5, Pages (May 2001)
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Volume 67, Issue 1, Pages (January 2005)
Integrin dependent protein tyrosine phosphorylation is a key regulatory event in collagen IV mediated adhesion and proliferation of human lung tumor cell.
Adenosine-induced apoptosis in glomerular mesangial cells
IL-2–mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP  Caigan Du, Qiunong Guan, Ziqin Yin, Robert.
Volume 69, Issue 4, Pages (February 2006)
Volume 57, Issue 4, Pages (April 2000)
Volume 67, Issue 3, Pages (March 2005)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 60, Issue 5, Pages (November 2001)
Difucosylated oligosaccharide Lewis Y is contained within integrin αvβ3 on RL95-2 cells and required for endometrial receptivity  Dongmei Zhang, Ph.D.,
Volume 64, Issue 1, Pages (July 2003)
Regulation of apoptosis by lethal cytokines in human mesothelial cells
Volume 64, Issue 6, Pages (December 2003)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 53, Issue 5, Pages (May 1998)
Volume 63, Issue 2, Pages (February 2003)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 59, Issue 1, Pages (January 2001)
Volume 67, Issue 6, Pages (June 2005)
Hyaluronan and proximal tubular cell migration
Volume 68, Issue 1, Pages (July 2005)
Volume 65, Issue 5, Pages (May 2004)
Volume 56, Issue 5, Pages (November 1999)
Volume 64, Issue 5, Pages (November 2003)
Volume 66, Issue 4, Pages (October 2004)
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 5, Pages (May 2001)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 62, Issue 3, Pages (September 2002)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Inhibition of glomerular cell apoptosis by heparin
Volume 79, Issue 8, Pages (April 2011)
E. Boulanger, N. Grossin, M.-P. Wautier, R. Taamma, J.-L. Wautier 
Volume 65, Issue 5, Pages (May 2004)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 58, Issue 3, Pages (September 2000)
Volume 62, Issue 3, Pages (September 2002)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Volume 75, Issue 5, Pages (March 2009)
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 59, Issue 2, Pages (February 2001)
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Volume 53, Issue 4, Pages (April 1998)
Volume 61, Issue 5, Pages (May 2002)
The pathological role of Bax in cisplatin nephrotoxicity
FGF Expression Allows Nevus Cells to Survive in Three-Dimensional Collagen Gel Under Conditions that Induce Apoptosis in Normal Human Melanocytes  Tuomo.
Volume 58, Issue 1, Pages (July 2000)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 60, Issue 1, Pages (July 2001)
Tumor necrosis factor-α and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells  Udo K. Meßmer, Verena A. Briner, Josef.
Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: Impact on proliferation and apoptosis  Shao-Ling Zhang, Jun Guo, Babak Moini, Julie.
Volume 60, Issue 3, Pages (September 2001)
Volume 64, Issue 3, Pages (September 2003)
Volume 67, Issue 6, Pages (June 2005)
Volume 54, Issue 4, Pages (October 1998)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 56, Issue 6, Pages (December 1999)
Cultured human glomerular mesangial cells express the C5a receptor
Volume 68, Issue 5, Pages (November 2005)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Volume 60, Issue 2, Pages (August 2001)
Presentation transcript:

Volume 59, Issue 5, Pages 1842-1849 (May 2001) Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC  Ciro Esposito, Gianluca Fasoli, Annarita Plati, Nicoletta Bellotti, Maria Maddalena Conte, Flavia Cornacchia, Annalisa Foschi, Tiziana Mazzullo, Luca Semeraro, Antonio Dal Canton  Kidney International  Volume 59, Issue 5, Pages 1842-1849 (May 2001) DOI: 10.1046/j.1523-1755.2001.0590051842.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Effect of short- and long-term high glucose on endothelial cell proliferation. Endothelial cells exposed to high glucose for 24 hours and 8 weeks were plated in a 24-well plate (5 × 104 cell/well) and allowed to attach. At the indicated times cells were counted. Low-glucose cultured cells were used as controls. Symbols are: (□) high-glucose and low-glucose (▪) 24-hour exposure; (▵) high-glucose and low-glucose (▴) eight-week exposure. The results are expressed as means ± SD. **P < 0.01 vs. short-term high glucose. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Effect of high-glucose, long-term exposure on endothelial cell morphology. Endothelial cells were cultured with high-glucose-containing media for eight weeks. They were fixed with paraformaldehyde (2%), and cell morphology was evaluated by phase-contrast microscopy (×40). (A) Low-glucose-treated cells. (B) High-glucose-treated cells. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Apoptosis in endothelial cell cultures treated with high glucose. Endothelial cells were cultured with high-glucose-containing media for 24 hours and for 8 weeks. Twenty microliters of cell lysate supernatant was assayed for oligonucleosomal DNA using a cell death-detection ELISA kit. Symbols are: (□) low-glucose- and (▪) high-glucose-treated cells. The results are expressed as means ± SD. *P < 0.05 vs. short-term low glucose. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Effect of short- and long-term high glucose exposure on (α2)IV collagen mRNA and protein in endothelial cell cultures. (A) Endothelial cells were cultured for 24 hours and for 8 weeks with high-glucose media. Media were then changed with media containing 0.1% fetal calf serum. After 24 hours, media were collected. Cells were counted, and ELISA for collagen type IV was performed. (B) (α2)IV and β-actin mRNA levels were analyzed by reverse transcription-polymerase chain reaction. (C) Densitometric analysis. Symbols are: (▪) low-glucose- and (□) high-glucose-treated cells. Results are expressed as means ± SD. ***P < 0.001 vs. long-term low glucose. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Effect of short- and long-term high glucose exposure on the expression of VCAM-1 on endothelial cells. Endothelial cells were cultured for 24 hours and 8 weeks with high glucose. VCAM-1 expression on cell surface was then evaluated by flow cytometry using anti-VCAM-1 antibody. In some experiments, cells were incubated with staurosporin and mannitol. Symbols are: (▪) low-glucose- and (□) high-glucose-treated cells; () cells pretreated with staurosporine; () cells treated with mannitol. Results are expressed as means ± SD. ***P < 0.001 vs. long-term low glucose vs. staurosporine vs. mannitol. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Immunoblotting of solubilized cell membrane from long-term high-glucose- and low-glucose-treated endothelial cells. Cells were treated for eight weeks with low and high glucose. Cell membranes were solubilized. Protein samples were separated by gel electrophoresis, and immunoblot was performed as described in the Methods section. Abbreviations are: M, markers; C, VCAM-1; 5 mmol/L, cell membrane protein sample from low-glucose-treated endothelial cells; 30mmol/L, cell membrane protein sample from high-glucose-treated endothelial cells. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 PBMC adhesion to the endothelial cell monolayer. Endothelial cells were cultured for 24 hours and 8 weeks with high glucose. PBMCs were added to culture media. After incubation for two hours at 37°C, nonadherent cells were removed, and adherent cells were counted. Symbols are: (▪) low-glucose- and (□) high-glucose-treated cells; () high-glucose + anti-VCAM-1 antibody-treated cells; () low-glucose + AGE-albumin-treated cells; () low-glucose + AGE-albumin + anti-RAGE antibody-treated cells; () high-glucose + anti-RAGE antibody-treated cells; () high glucose + cycloheximide-treated cells. Results are expressed as means ± SD. *P < 0.05 short-term high glucose vs. short-term low glucose; **P < 0.01 short-term low glucose + AGE-albumin vs. short-term low glucose + AGE-albumin + anti-RAGE antibody; #P < 0.01 long-term high glucose vs. long-term low glucose vs. long-term high glucose + anti-VCAM-1 antibody vs. long-term high glucose + anti-RAGE antibody. Kidney International 2001 59, 1842-1849DOI: (10.1046/j.1523-1755.2001.0590051842.x) Copyright © 2001 International Society of Nephrology Terms and Conditions